Drug Profile
DPX 0907
Alternative Names: DPX-0907Latest Information Update: 17 May 2018
Price :
$50
*
At a glance
- Originator Immunovaccine
- Class Cancer vaccines
- Mechanism of Action Immunostimulants; T lymphocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Ovarian cancer; Prostate cancer